United States Travel Vaccines Market Report 2017

In this report, the United States Travel Vaccines market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
The West
Southwest
The Middle Atlantic
New England
The South
The Midwest
with sales (volume), revenue (value), market share and growth rate of Travel Vaccines in these regions, from 2012 to 2022 (forecast).

United States Travel Vaccines market competition by top manufacturers/players, with Travel Vaccines sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
Pfizer
Sanofi
GlaxoSmithKline
Merck
AstraZeneca
Janssen Pharmaceuticals
Abbott
Mitsubishi Tanabe Pharma
LG Life Sciences
Roche
Lupin
Takeda Pharmaceutical
Valeant Pharmaceuticals
SK Chemicals
Hualan Biological Engineering
Indian Immunologicals
Serum Institute of India
GlycoVaxyn
Beijing Minhai Biotechnology
Shenzhen Kangtai Biological Products

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
Mono Vaccines
Combination Vaccines
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Travel Vaccines for each application, including
Domestic Travel
Outbound Travel

If you have any special requirements, please let us know and we will offer you the report as you want.